CLSD Clearside Biomedical Inc

Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.

$1.60  -0.05 (-3.03%)
As of 06/27/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/02/2016
Outstanding shares:  60,150,442
Average volume:  171,415
Market cap:   $99,248,229
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZ6VT37
Valuation   (See tab for details)
PE ratio:   1,196.52
PB ratio:   3.13
PS ratio:   3.82
Return on equity:   0.26%
Net income %:   0.32%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy